Loading clinical trials...
Loading clinical trials...
Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)
Conditions
Interventions
Lysergic Acid Diethylamide Tartrate
Lysergic Acid Diethylamide Tartrate
Locations
4
Switzerland
University Hospital Basel, Division of Clinical Pharmacology and Toxicology
Basel, Switzerland
University Hospital Geneva, Palliative medicine department
Collonge-Bellerive, Switzerland
Spital Uster AG, Division of Internal Medicine
Uster, Switzerland
University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative Care
Zurich, Switzerland
Start Date
June 9, 2024
Primary Completion Date
September 1, 2027
Completion Date
May 1, 2028
Last Updated
April 23, 2026
NCT07548385
NCT04577690
NCT07547774
NCT07543952
NCT07060495
NCT07538427
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions